Pay vs Performance Disclosure, Table

The following table reports the compensation of our Principal Executive Officer (PEO) and the average compensation of the other Named Executive Officers (Other NEOs) as reported in the Summary Compensation Table for the past five fiscal years, as well as their “compensation actually paid” as calculated pursuant to SEC rules and certain performance measures required by the rules.


	Summary Compensation Table Total for PEO ($)(1)	Compensation Actually Paid to PEO ($)(2)(3)	Average Summary Compensation Table Total for Other NEOs ($)(1)	Average Compensation Actually Paid to Other NEOs ($)(2)(3)	Value of Initial Fixed $100 Investment Based On(4):			Company-Selected Measure(5)

Year					IQVIA’s Total Stockholder Return ($)	Peer Group Total Stockholder Return ($)	Net Income ($ millions)	Adjusted Diluted EPS Growth (%)(6)

(a)	(b)	(c)	(d)	(e)	(f)	(g)	(h)	(i)

2025	28,128,245	36,068,712	8,869,621	11,081,528	125.81	186.82	1,360	7.1
2024	26,732,998	11,450,139	6,575,714	4,095,455	109.68	158.83	1,373	9.1
2023	29,151,752	42,292,899	4,523,047	4,103,793	129.14	147.52	1,358	0.4
2022	30,135,029	5,961,064	5,007,016	1,702,449	114.36	137.91	1,091	12.5
2021	28,615,851	88,421,980	4,395,745	10,062,332	157.47	136.17	966	40.7

Company Selected Measure Name

Adjusted Diluted EPS Growth

Named Executive Officers, Footnote

Ari Bousbib was our PEO for each year presented. The individuals comprising the Other NEOs for each year presented are listed below:

2021

2022

2023

2024

2025

Ronald E. Bruehlman

W. Richard Staub, III

Costa Panagos

W. Richard Staub, III

Kevin C. Knightly

Bhavik Patel

Alistair R. Grenfell

Eric M. Sherbet

Costa Panagos

Peer Group Issuers, Footnote

The compensation peer group for each listed fiscal year consists of the companies listed as our compensation benchmarking peer group in the Compensation Discussion & Analysis. For 2025, the companies included AbbVie Inc., Accenture plc, Agilent Technologies, Inc., Amgen Inc., Avantor, Inc., Biogen Inc., Bristol Myers Squibb Co., Cognizant Technology Solutions Corp., Danaher Corporation, Eli Lilly & Co., Gartner, Inc., Gilead Sciences, Inc., International Business Machines Corp., ICON Plc, Laboratory Corp of America Holdings, Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals Inc., and Zoetis Inc.

PEO Total Compensation Amount

$ 28,128,245

$ 26,732,998

$ 29,151,752

$ 30,135,029

$ 28,615,851

PEO Actually Paid Compensation Amount

$ 36,068,712

11,450,139

42,292,899

5,961,064

88,421,980

Adjustment To PEO Compensation, Footnote

Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Other NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.


Year	Summary Compensation Table Total for PEO ($)	Exclusion of Change in Pension Value for PEO ($)	Exclusion of Stock Awards and Option Awards for PEO ($)	Inclusion of Pension Service Cost for PEO ($)	Inclusion of Equity Values for PEO ($)	Compensation Actually Paid to PEO ($)

2025	28,128,245	(689,848)	(20,278,274)	270,289	28,638,300	36,068,712
2024	26,732,998	(707,772)	(20,238,983)	279,972	5,383,924	11,450,139
2023	29,151,752	(844,991)	(21,157,852)	258,365	34,885,625	42,292,899
2022	30,135,029	(420,742)	(21,388,958)	296,785	(2,661,050)	5,961,064
2021	28,615,851	(535,539)	(18,534,470)	314,052	78,562,087	88,421,980

The amounts for Messrs. Grenfell and Patel have been converted from GBP to U.S. dollars using the average of the monthly average exchange rates for 2025 and 2024, respectively.

The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:


Year	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO ($)	Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO ($)	Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for PEO ($)	Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO ($)	Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for PEO ($)	Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Included for PEO ($)	Total - Inclusion of Equity Values for PEO ($)

2025	24,951,534	3,156,942	—	529,824	—	—	28,638,300
2024	17,350,975	(6,450,390)	—	(3,738,897)	(1,777,764)	—	5,383,924
2023	22,020,972	1,379,297	—	11,485,356	—	—	34,885,625
2022	16,869,138	(15,553,971)	—	(3,976,217)	—	—	(2,661,050)
2021	34,647,149	25,065,538	—	18,849,400	—	—	78,562,087

Non-PEO NEO Average Total Compensation Amount

$ 8,869,621

6,575,714

4,523,047

5,007,016

4,395,745

Non-PEO NEO Average Compensation Actually Paid Amount

$ 11,081,528

4,095,455

4,103,793

1,702,449

10,062,332

Adjustment to Non-PEO NEO Compensation Footnote


Year	Average Summary Compensation Table Total for Other NEOs ($)	Average Exclusion of Change in Pension Value for Other NEOs ($)	Average Exclusion of Stock Awards and Option Awards for Other NEOs ($)	Average Inclusion of Pension Service Cost for Other NEOs ($)	Average Inclusion of Equity Values for Other NEOs ($)	Average Compensation Actually Paid to Other NEOs ($)

2025	8,869,621	(44,456)	(6,999,883)	16,601	9,239,646	11,081,528
2024	6,575,714	(40,796)	(4,937,350)	15,913	2,481,974	4,095,455
2023	4,523,047	(73,164)	(3,228,937)	17,778	2,865,069	4,103,793
2022	5,007,016	(46,106)	(3,363,826)	22,217	83,148	1,702,449
2021	4,395,745	(45,384)	(2,548,372)	23,204	8,237,139	10,062,332


Year	Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Other NEOs ($)	Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Other NEOs ($)	Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Other NEOs ($)	Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Other NEOs ($)	Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Other NEOs ($)	Average Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Included for Other NEOs ($)	Total - Average Inclusion of Equity Values for Other NEOs ($)

2025	8,317,047	828,084	—	94,514	—	—	9,239,646
2024	4,043,003	(844,438)	—	(484,051)	(232,541)	—	2,481,974
2023	2,411,696	153,127	—	1,274,065	(973,819)	—	2,865,069
2022	2,660,228	(2,066,942)	—	(510,138)	—	—	83,148
2021	4,763,789	2,005,653	—	1,467,697	—	—	8,237,139

Compensation Actually Paid vs. Total Shareholder Return

Relationship Between Compensation Actually Paid and Performance Measures

In light of the significant weighting of long-term stock-based incentives in our pay mix due to the intended alignment between our named executive officers and stockholders, the Compensation Actually Paid values are significantly influenced by the value of IQVIA’s stock price. The table below reflects the relationship between the PEO and the average Other NEO compensation actually paid and the performance measures shown in the pay versus performance table from 2021 to 2025:


Period	Compensation Actually Paid to PEO			Average Compensation Actually Paid to Other NEOs			IQVIA’s TSR			Peer Group TSR			Net Income			Adj. Diluted EPS Growth

2021 to 2025	(59)	%	â	10	%	á	26	%	á	87	%	á	41	%	á	86	%	á

●Relationship Between Compensation Actually Paid to our PEO and the Average of the Compensation Actually Paid to the Other NEOs and the Company’s Cumulative TSR. From 2021 to 2025, the compensation actually paid to our PEO decreased by 59% and the average of the compensation actually paid to the Other NEOs increased by 10%, compared to a 26% increase in our TSR over the same time period.

●Relationship Between Compensation Actually Paid to our PEO and the Average of the Compensation Actually Paid to the Other NEOs and the Company’s Net Income. From 2021 to 2025, the compensation actually paid to our PEO decreased by 59% and the average of the compensation actually paid to the Other NEOs increased by 10%, compared to a 41% increase in our Net Income over the same time period.

●Relationship Between Compensation Actually Paid to our PEO and the Average of the Compensation Actually Paid to the Other NEOs and the Company’s Adjusted Diluted EPS Growth. From 2021 to 2025, the compensation actually paid to our PEO decreased by 59% and the average of the compensation actually paid to the Other NEOs increased by 10%, compared to a 86% increase in our Adjusted Diluted EPS over the same time period.

●Relationship Between the Company’s TSR and the Peer Group TSR. The TSR for the peer group disclosed in the table above increased by 87% from 2021 to 2025 as compared to the Company’s TSR, which increased by 26% over the same time period.

Compensation Actually Paid vs. Net Income

Relationship Between Compensation Actually Paid and Performance Measures


Period	Compensation Actually Paid to PEO			Average Compensation Actually Paid to Other NEOs			IQVIA’s TSR			Peer Group TSR			Net Income			Adj. Diluted EPS Growth

2021 to 2025	(59)	%	â	10	%	á	26	%	á	87	%	á	41	%	á	86	%	á

Compensation Actually Paid vs. Company Selected Measure

Relationship Between Compensation Actually Paid and Performance Measures


Period	Compensation Actually Paid to PEO			Average Compensation Actually Paid to Other NEOs			IQVIA’s TSR			Peer Group TSR			Net Income			Adj. Diluted EPS Growth

2021 to 2025	(59)	%	â	10	%	á	26	%	á	87	%	á	41	%	á	86	%	á

Total Shareholder Return Vs Peer Group

Relationship Between Compensation Actually Paid and Performance Measures


Period	Compensation Actually Paid to PEO			Average Compensation Actually Paid to Other NEOs			IQVIA’s TSR			Peer Group TSR			Net Income			Adj. Diluted EPS Growth

2021 to 2025	(59)	%	â	10	%	á	26	%	á	87	%	á	41	%	á	86	%	á

Tabular List, Table


			Performance Metrics

			Adjusted Diluted EPS Growth (as defined in “Compensation Discussion and Analysis—Elements of Compensation—Short-Term Incentive Awards,” described on page 57)
			Relative Total Stockholder Return (as defined in “Compensation Discussion and Analysis—Elements of Compensation— Long-Term Incentive Awards,” described on page 60)
			Revenue (as defined in “Compensation Discussion and Analysis—Elements of Compensation—Short-Term Incentive Awards,” described on page 57)
			Adjusted EBITDA (as defined in “Compensation Discussion and Analysis—Elements of Compensation—Short-Term Incentive Awards,” described on page 57)

Total Shareholder Return Amount

$ 125.81

109.68

129.14

114.36

157.47

Peer Group Total Shareholder Return Amount

186.82

158.83

147.52

137.91

136.17

Net Income (Loss)

$ 1,360,000,000

$ 1,373,000,000

$ 1,358,000,000

$ 1,091,000,000

$ 966,000,000

Company Selected Measure Amount

0.071

0.091

0.004

0.125

0.407

PEO Name

Ari Bousbib

Additional 402(v) Disclosure

The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v)(2)(iii) of Regulation S-K and do not reflect compensation actually earned, realized or received by the PEO or Other NEOs. The amounts for Messrs. Grenfell and Patel have been converted from GBP to U.S. dollars using the average of the monthly average exchange rates for 2025 and 2024, respectively. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.

Measure:: 1

Non-GAAP Measure Description

Adjusted Diluted EPS Growth (as defined in “Compensation Discussion and Analysis—Elements of Compensation—Short-Term Incentive Awards,” described on page 57)

The Company has identified Adjusted Diluted EPS Growth as the company-selected measure for the pay versus performance disclosure, as it represents the most important financial performance measure used to link compensation actually paid to the PEO and the Other NEOs in 2025 to the Company’s performance. See Appendix A in this Proxy Statement for a reconciliation of Adjusted Diluted EPS Growth, a non-GAAP measure, to the most directly comparable GAAP measure.

Measure:: 2

Relative Total Stockholder Return (as defined in “Compensation Discussion and Analysis—Elements of Compensation— Long-Term Incentive Awards,” described on page 60)

Measure:: 3

Revenue (as defined in “Compensation Discussion and Analysis—Elements of Compensation—Short-Term Incentive Awards,” described on page 57)

Measure:: 4

PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table

Adjusted EBITDA (as defined in “Compensation Discussion and Analysis—Elements of Compensation—Short-Term Incentive Awards,” described on page 57)

PEO | Pension Adjustments Service Cost

$ (689,848)

$ (707,772)

$ (844,991)

$ (420,742)

$ (535,539)

PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

270,289

279,972

258,365

296,785

314,052

PEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table

(20,278,274)

(20,238,983)

(21,157,852)

(21,388,958)

(18,534,470)

PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

28,638,300

5,383,924

34,885,625

(2,661,050)

78,562,087

PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

24,951,534

17,350,975

22,020,972

16,869,138

34,647,149

PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

3,156,942

(6,450,390)

1,379,297

(15,553,971)

25,065,538

PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

529,824

(3,738,897)

11,485,356

(3,976,217)

18,849,400

PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year

(1,777,764)

Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table

Non-PEO NEO | Pension Adjustments Service Cost

(44,456)

(40,796)

(73,164)

(46,106)

(45,384)

Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

16,601

15,913

17,778

22,217

23,204

Non-PEO NEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table

(6,999,883)

(4,937,350)

(3,228,937)

(3,363,826)

(2,548,372)

Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

9,239,646

2,481,974

2,865,069

83,148

8,237,139

Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

8,317,047

4,043,003

2,411,696

2,660,228

4,763,789

Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

828,084

(844,438)

153,127

(2,066,942)

2,005,653

Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

94,514

(484,051)

1,274,065

(510,138)

1,467,697

Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year

(232,541)

(973,819)